President Joe Biden’s Inflation Reduction Act gave the government sweeping new power to set the price Medicare will pay for ...
Medicare negotiations of prescription drug prices could have cut seniors' out-of-pocket costs by nearly a quarter had the program been in effect in 2021, according to an analysis Mathematica provided ...
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies ...
The Biden administration unveiled a new framework outlining the factors federal agencies should consider in determining ...
Only one company has responded to an FTC demand for several drugmakers to delist dozens of patents that were improperly or ...
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were ...
We all know that policymakers are increasingly focused on lowering drug costs. From the Inflation Reductions Act's Medicare price negotiations (aka price controls) to the recent proposals directed at ...
In terms of therapeutic breakthroughs, Isasi suggested that the drug price negotiation program’s current structure is an effective deterrent from drugmakers’ low-impact profit chasing. “In ...
Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...
Through the deal, AbbVie gains Elahere that is approved for ovarian cancer patients who have received previous therapies, and ...
Bitcoin is entering 2024 with bullish momentum. Experts anticipate the SEC will approve the first spot bitcoin ETF in the near future. The original crypto is on track for its next halving in April ...
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an ...
